Sinha Vikas
Chief Financial Officer | See Remarks
2 companies
Insider Signal Score
84
ExcellentTrades Analyzed
39
12M Win Rate
97.4%
Avg 3M Return
+19.2%
Avg 12M Return
+60.5%
Sinha Vikas is a Chief Financial Officer at Scholar Rock Holding Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $27.8M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | SRRK Scholar Rock Holding Corp | Chief Financial Officer | Sell | 16,755 | $42.70 | $715,438.50 | -2.8% | +14.2% | - | |
| Feb 21, 2025 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 303 | $10.08 | $3,052.97 | -0.6% | -70.6% | +3.8% | |
| Jan 23, 2025 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 129 | $9.50 | $1,225.86 | -0.1% | -31.2% | -3.8% | |
| Jan 10, 2025 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 979 | $0.44 | $430.86 | - | -27.6% | -3.2% | |
| Nov 19, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,186 | $0.55 | $1,747.52 | -0.3% | -25.6% | -48.1% | |
| Nov 5, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 5,136 | $0.86 | $4,442.13 | -0.4% | -57.0% | -78.0% | |
| Oct 22, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,428 | $0.77 | $2,649.33 | -0.1% | -47.6% | -75.5% | |
| Oct 3, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 940 | $0.81 | $765.91 | - | -45.0% | -64.7% | |
| Aug 19, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,159 | $0.76 | $2,399.26 | -0.3% | -24.6% | -85.4% | |
| Aug 5, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 5,251 | $0.73 | $3,858.43 | -0.5% | +21.3% | -84.8% |
Page 1Next →